Overexpression of hMTH in peripheral lymphocytes and risk of prostate cancer: A case-control analysis

Molecular Carcinogenesis

Volumn 36, Issue 3, 2003, Pages 123-129

  Liu, Zhensheng ^a   Wang, Li E ^a   Strom, Sara S ^a   Spitz, Margaret R ^a   Babaian, Richard J ^a   DiGiovanni, John ^b   Wei, Qingyi ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

DNA repair; Genetic susceptibility; HMTH expression; Oxidative stress; Prostate cancer

Indexed keywords

ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTINS; CASE-CONTROL STUDIES; DNA DAMAGE; DNA GLYCOSYLASES; DNA REPAIR ENZYMES; DNA-FORMAMIDOPYRIMIDINE GLYCOSYLASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; N-GLYCOSYL HYDROLASES; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; OXIDATIVE STRESS; PHOSPHORIC MONOESTER HYDROLASES; PHYTOHEMAGGLUTININS; PILOT PROJECTS; PROSTATIC NEOPLASMS; REFERENCE VALUES; REGRESSION ANALYSIS; RISK FACTORS; RNA, MESSENGER; TEXAS;

EID: 0037335523     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.10108     Document Type: Article

References (34)

1. American Cancer Society Inc. Cancer Facts & Figures 2002. Atlanta: American Cancer Society, 2002.
2. Bosland MC. The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr 2000;27:39-66.
3. Newcomer LM, King IB, Wicklund KG, Stanford JL. The association of fatty acids with prostate cancer risk. Prostate 2001;47:262-268.
4. Kristal AR, Stanford JL, Cohen JH, Wicklund K, Patterson RE. Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1999;8:887-892.
5. Cai X, Haleem R, Oram S. High fat diet increases the weight of rat ventral prostate. Prostate 2001;49:1-8.
6. Fleshner N, Fair WR, Huryk R, Heston WD. Vitamin E inhibits the high-fat diet promoted growth of established human prostate LNCaP tumors in nude mice. J Urol 1999;161: 1651-1654.
7. Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WD. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 1995;87:1456-1462.
8. Fleshner NE, Klotz LH. Diet, androgens, oxidative stress and prostate cancer susceptibility. Cancer Metastasis Rev 1998-1999;17:325-330.
9. Fleshner NE, Kucuk O. Antioxidant dietary supplements: Rationale and current status as chemopreventive agents for prostate cancer. Urology 2001;57:90-94.
10. Halliwell B. Free radicals, antioxidants and human disease: Curiosity, cause or consequence? Lancet 1994;344:721-724.
11. Jackson AL, Loeb LA. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res 2001;477:7-21.
12. Ambrosone CB. Oxidants and antioxidants in breast cancer. Antioxid Redox Signal 2000;2:903-917.
13. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91:1194-1210.
14. Oberley TD, Zhong W, Szweda LI, Oberley LW. Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium. Prostate 2000; 44:144-155.
15. Bostwick DG, Alexander EE, Singh R. Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer 2000;89:123-134.
16. Michaels ML, Cruz C, Grollman AP, Miller JH. Evidence that MutY and MutM combine to prevent mutations by an oxidatively damaged form of guanine in DNA. Proc Natl Acad Sci USA 1992;89:7022-7025.
17. Maki H, Sekiguchi M. MutT protein specifically hydrolyses a potent mutagenic substrate for DNA synthesis. Nature 1992;355:273-275.
18. Aburatani H, Hippo Y, Ishida T. Cloning and characterization of mammalian 8-hydroxyguanine-specific DNA glycosylase/ apurinic, apyrimidinic lyase, a functional mutM homologue. Cancer Res 1997;57:2151-2156.
19. Sakumi K, Furuichi M, Tsuzuki T. Cloning and expression of cDNA for a human enzyme that hydrolyzes 8-oxo-dGTP, a mutagenic substrate for DNA synthesis. J Biol Chem 1993; 268:23524-23530.
20. Slupska MM, Baikalov C, Luther WM, Chiang JH, Wei YF, Miller JH. Cloning and sequencing a human homolog (hMYH) of the Escherichia coli mutY gene whose function is required for the repair of oxidative DNA damage. J Bacteriol 1996;178:3885-3892.
21. Okamoto K, Toyokuni S, Kim W. Overexpression of human mutT homologue gene messenger RNA in renal-cell carcinoma: evidence of persistent oxidative stress in cancer. Int J Cancer 1996;65:437-441.
22. Kennedy CH, Cueto R, Belinsky SA, Lechner JF, Pryor WA. Overexpression of hMTH1 mRNA: A molecular marker of oxidative stress in lung cancer cells. FEBS Lett 1998;429:17-20.
23. Meyer F, Fiala E, Westendorf J. Induction of 8-oxo-dGTPase activity in human lymphoid cells and normal fibroblasts by oxidative stress. Toxicology 2000;146:83-92.
24. Szepesi A, Gelfand EW, Lucas JJ. Association of proliferating cell nuclear antigen with cyclin-dependent kinases and cyclins in normal and transformed human T lymphocytes. Blood 1994;84:3413-3421.
25. Tsujii M, Kawano S, Dubois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997;94:3336-3340.
26. Steinbach G, Lynch PM, Phillips RK. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946-1952.
27. Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science 2001;291:1284-1289.
28. Ames BN, Gold LS, Willet WC. Causes and prevention of cancer. Proc Natl Acad Sci USA 1995;92:5258-5265.
29. Fair WR, Fleshner NE, Heston W. Cancer of the prostate: A nutritional disease? Urology 1997;50:840-848.
30. Rao AV, Fleshner N, Agarwal S. Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: A case-control study. Nutr Cancer 1999;33:159-164.
31. Lee WH, Isaacs WB, Bova GS, Nelson WG. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: A new prostate cancer biomarker. Cancer Epidemiol Biomarkers Prev 1997;6:443-450.
32. Wei H. Activation of oncogenes and or inactivation of antioncogenes by reactive oxygen species. Med Hypotheses 1992;39:267-270.
33. Ripple MO, Henry WF, Rago RP, Wilding G. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J Natl Cancer Inst 1997;89:40-48.
34. Barret JM, Calsou P, Salles B. Deficient nucleotide excision repair activity in protein extracts from normal human lymphocytes. Carcinogenesis 1995;16:1611-1616.